PURPOSE:Extracorporeal shock wave therapy (ESWT) has been reported as a new therapy for carpal tunnel syndrome (CTS). However, few studies have compared ESWT with the local corticosteroid injection (LCI). METHODS: In this study, a randomized controlled trial comparing 30 patients with ESWT and 25 patients treated withLCI was conducted. The clinical outcomes were obtained with tests including the visual analog scale (VAS) for pain and paresthesia, the Boston Carpal Tunnel Questionnaire (BQ), and a nerve conduction study, before the study started and at three, nine, and 12 weeks after the start of the treatment. RESULTS: Significantly greater improvement in the VAS and BQ scores was noted for the ESWT group than for the LCI group (P < 0.05). For the nerve conduction study, there was a significant improvement in the median nerve sensory nerve action potential distal latency at the nine and 12-week follow-ups for the ESWT group. CONCLUSIONS:ESWT is a useful noninvasive short-term treatment for mild to moderate carpal tunnel syndrome and elicits a better recovery than LCI does, but more research is needed to test the clinical outcomes of ESWT.
RCT Entities:
PURPOSE: Extracorporeal shock wave therapy (ESWT) has been reported as a new therapy for carpal tunnel syndrome (CTS). However, few studies have compared ESWT with the local corticosteroid injection (LCI). METHODS: In this study, a randomized controlled trial comparing 30 patients with ESWT and 25 patients treated with LCI was conducted. The clinical outcomes were obtained with tests including the visual analog scale (VAS) for pain and paresthesia, the Boston Carpal Tunnel Questionnaire (BQ), and a nerve conduction study, before the study started and at three, nine, and 12 weeks after the start of the treatment. RESULTS: Significantly greater improvement in the VAS and BQ scores was noted for the ESWT group than for the LCI group (P < 0.05). For the nerve conduction study, there was a significant improvement in the median nerve sensory nerve action potential distal latency at the nine and 12-week follow-ups for the ESWT group. CONCLUSIONS: ESWT is a useful noninvasive short-term treatment for mild to moderate carpal tunnel syndrome and elicits a better recovery than LCI does, but more research is needed to test the clinical outcomes of ESWT.
Authors: Huixi Li; Melanie P Matheu; Fionna Sun; Lin Wang; Melissa T Sanford; Hongxiu Ning; Lia Banie; Yung-Chin Lee; Zhongcheng Xin; Yinglu Guo; Guiting Lin; Tom F Lue Journal: J Sex Med Date: 2016-01 Impact factor: 3.802
Authors: M Paoloni; E Tavernese; A Cacchio; V D'orazi; F Ioppolo; M Fini; V Santilli; M Mangone Journal: Eur J Phys Rehabil Med Date: 2015-02-20 Impact factor: 2.874
Authors: Linda S Chesterton; Milica Blagojevic-Bucknall; Claire Burton; Krysia S Dziedzic; Graham Davenport; Sue M Jowett; Helen L Myers; Raymond Oppong; Trishna Rathod-Mistry; Danielle A van der Windt; Elaine M Hay; Edward Roddy Journal: Lancet Date: 2018-10-20 Impact factor: 79.321
Authors: Mar Hernández-Secorún; Raquel Montaña-Cortés; César Hidalgo-García; Jacobo Rodríguez-Sanz; Jaime Corral-de-Toro; Sofia Monti-Ballano; Sami Hamam-Alcober; José Miguel Tricás-Moreno; María Orosia Lucha-López Journal: Int J Environ Res Public Health Date: 2021-02-28 Impact factor: 3.390
Authors: Christina Gesslbauer; Michael Mickel; Othmar Schuhfried; Dominikus Huber; Mohammad Keilani; Richard Crevenna Journal: Wien Klin Wochenschr Date: 2020-12-22 Impact factor: 1.704
Authors: Lei Lei; Shanshan Yin; Fanyuan Meng; Ya Zhou; Xuan Xu; Li Juan Ao; Rui Xu; Mo Xian Chen Journal: Medicine (Baltimore) Date: 2022-01-07 Impact factor: 1.889
Authors: Johannes C Heinzel; Viola Oberhauser; Claudia Keibl; Barbara Schädl; Nicole V Swiadek; Gregor Längle; Helen Frick; Cyrill Slezak; Cosima Prahm; Johannes Grillari; Jonas Kolbenschlag; David Hercher Journal: Biomedicines Date: 2022-07-22